title: Does aprotinin really reduce blood loss in orthotopic liver transplantation?
authors.affiliation: Institute of Anesthesiology, Ludwig-Maximilians-University, Munich, Germany.
authors.forename: J
authors.initials: J
authors.lastname: Groh
authors.forename: M
authors.initials: M
authors.lastname: Welte
authors.forename: S C
authors.initials: SC
authors.lastname: Azad
authors.forename: M
authors.initials: M
authors.lastname: Anthuber
authors.forename: M
authors.initials: M
authors.lastname: Haller
authors.forename: M A
authors.initials: MA
authors.lastname: Kratzer
mesh_terms: D000328:Adult; D000368:Aged; D007611:Aprotinin / Q000627:therapeutic use*; D001780:Blood Coagulation Tests; D016063:Blood Loss, Surgical / Q000517:prevention & control*; D004311:Double-Blind Method; D005342:Fibrinolysis; D006488:Hemostasis, Surgical / Q000379:methods*; D006801:Humans; D016031:Liver Transplantation / Q000009:adverse effects*; D008875:Middle Aged; D016343:Monitoring, Intraoperative; D011446:Prospective Studies; D017211:Treatment Failure
chemical_list: D007611:Aprotinin